1.. Introduction {#s1}
================

A number of human cell lines have been established from the various tissues of normal individuals, as well as patients with a range of cancers. These resources have been used in a broad research area, including as an experimental model for drug development and to gain a deeper understanding of molecular pathogenesis. General guidelines for the use of cell lines are provided to obtain reliable data from experiments using cultured cells \[[@RSOS172472C1],[@RSOS172472C2]\]. Authentication failures caused by cross-contamination or misidentification and mycoplasma contamination are fundamental issues, which affect the quality of materials in cell culture \[[@RSOS172472C3]--[@RSOS172472C6]\]. However, these concerns can be avoided by following the guidelines in accordance with best practices \[[@RSOS172472C7],[@RSOS172472C8]\].

A diverse range of viruses have been identified within specific tissues and reported in relation to disease pathogenesis \[[@RSOS172472C9]\]. Human tissue samples are often subjected to viral infection in diagnostic laboratories and certain viral tests are performed in routine clinical practice. For example, the human herpesvirus family is known as a common pathogen that causes disease in humans, and has been investigated in clinical samples \[[@RSOS172472C10]\]. A method of detecting the herpesviruses has been established based on multiplex real-time PCR, and this assay has been applied in clinical samples, demonstrating a robust screening method \[[@RSOS172472C11]\]. Although human cell lines could potentially carry a virus through an establishment, little attention has been paid to the possibility of viral infections in cell samples.

When viruses enter the human body, they proliferate in susceptible cells and establish an infection. This can cause illness with clinical symptoms such as fever, rash or headache, leading to a certain type of infectious disease unique to infected tissues. Alternatively, viruses are often observed in a latent state, which is sometimes related to reactivation \[[@RSOS172472C12]\]. Viruses are structurally classified by genome types, DNA and RNA, which are represented by herpesviruses and retroviruses, respectively ([table 1](#RSOS172472TB1){ref-type="table"}). DNA viruses retain the ability to repair mismatched base pairs, exhibiting low diversity. RNA viruses are sorted into two groups distinguished by the presence or absence of reverse transcriptase. Because of reverse transcription of the viral RNA into DNA, retroviruses, such as human T-cell leukaemia virus (HTLV) and human immunodeficiency virus (HIV), can be detected in cellular DNA. These RNA viruses are known to be integrated in host cell genome DNA after infection. Table 1.List of pathogenic viruses examined in human cell lines. CMV, cytomegalovirus; EBV, Epstein-Barr virus; HHV-6, human herpesvirus 6; HHV-7, human herpesvirus 7; BKV, human polyomavirus BK; JCV, human polyomavirus JC; ADV, human adenovirus; B19V, human parvovirus B19; HBV, hepatitis B virus; HTLV-1, human T-cell leukaemia virus type 1; HTLV-2, human T-cell leukaemia virus type 2; HIV-1, human immunodeficiency virus 1; HIV-2, human immunodeficiency virus 2; HAV, hepatitis A virus; HCV, hepatitis C virus.namegenome typeviral tropismrelated diseaseviral DNA testviral RNA testCMVDNAmonocyte, epithelial cells, endothelial cellsbirth defects, cytomegalic inclusion disease○EBVDNAB-cell, epithelial cellsinfectious mononucleosis, Burkitt lymphoma, nasopharyngeal cancer, CNS lymphoma, leukaemia○HHV-6DNAT-cell, NK cellexanthem subitum (HHV-6B)○HHV-7DNAT-cellexanthem subitum, febrile convulsions○BKVDNAreno-urinary tracthaemorrhagic cystitis after allogeneic haematopoietic stem cell transplantation○JCVDNAreno-urinary tract, brainprogressive multifocal leucoencephalopathy in HIV-AIDS, haemorrhagic cystitis after allogeneic haematopoietic stem cell transplantation○ADVDNAgenitourinary tracthaemorrhagic cystitis after allogeneic haematopoietic stem cell transplantation○B19VDNAerythroid cells, skin, livererythema infectiosum, arthritis, chronic anaemia etc.○HBVDNAhepatocytehepatitis, cirrhosis and hepatocellular carcinoma○HTLV-1RNAT-cellhuman T-cell leukaemia○○HTLV-2RNAT-cellhuman T-cell leukaemia○○HIV-1RNACD4 (+) T-cellAIDS○○HIV-2RNACD4 (+) T-cellAIDS○○HAVRNAhepatocytehepatitis○HCVRNAhepatocytehepatitis, cirrhosis and hepatocellular carcinoma○

Certain types of viruses are employed to induce cellular oncogenesis and immortalization \[[@RSOS172472C13]\], represented by Epstein--Barr virus (EBV), discovered as the first human oncogenic virus. EBV-transformed lymphoblastoid cell lines are conventionally established from patients with congenital anomalies to provide continuous supplies of genomic DNA as a valuable resource \[[@RSOS172472C14]\]. In contrast to viruses experimentally used for transformation *in vitro*, some viruses originated from *in vivo* infection are detected in certain cell lines. It is reported that HHV-8 was detected in human cell lines specifically derived from primary effusion lymphomas \[[@RSOS172472C15]\]. Screening for seven kinds of viruses has been performed in 460 primate cell lines, revealing that some samples were positive for EBV by PCR but negative by southern blot \[[@RSOS172472C16]\]. This implies that the presence of viruses in cell lines can be more accurately detected by PCR.

Bacterial contamination is visually found in cell cultures through a conventional light microscope, and can be prevented using antibiotics. However, virus detection requires molecular analysis, and, once cells have become infected the viruses cannot be easily removed from the cells. Datasets from virus examination in cell lines contribute to the safe management of cell culture and characterization of cell lines. In this report, we have screened for 15 viruses in 844 human cell lines registered with the Japanese Collection of Research Bioresources (JCRB) Cell Bank and have detected six different viruses in 43 cell lines.

2.. Material and methods {#s2}
========================

2.1.. Cell lines {#s2a}
----------------

Cell lines examined in this study are registered with the JCRB Cell Bank and are listed in the electronic supplementary material, table S1. These cells had been authenticated by short tandem repeat (STR) analysis and had been confirmed as mycoplasma-negative in our routine quality control. Certain cell lines carrying the same name appear with different registration numbers. These cell lines were deposited by various depositors through different routes, and would normally have the same characteristics, but there is the possibility of subtle strain differences.

2.2.. Microbiological tests {#s2b}
---------------------------

The residual cells from every freezing lot were inoculated into two tubes and one agar plate (NB medium---nutrient broth with 2% yeast extract, thioglycollate medium, 1-blood agar plate) for a sterility test. These tubes and plates were incubated at 35°C for 2 weeks to examine bacterial and fungal contamination.

2.3.. DNA and RNA extraction {#s2c}
----------------------------

Total DNA and RNA samples were extracted from each cell line with the AllPrep DNA/RNA Mini kit (QIAGEN, Germany, 80204). Some DNA was prepared by a conventional protocol using phenol--chloroform. When extracting RNA for copy number titration, DNA contamination was eliminated by digestion with RNase-free DNase I (QIAGEN, Germany, 79254) at room temperature.

2.4.. Detection of viral DNA with real-time PCR {#s2d}
-----------------------------------------------

The viral DNA test was targeted to nine and four kinds of DNA and RNA viruses, respectively ([table 1](#RSOS172472TB1){ref-type="table"}), CMV, EBV, BKV, JCV, HHV-6, HHV-7, ADV, B19V, HBV, HTLV-1, HTLV-2, HIV-1 and HIV-2, and performed using customized 96-well plates inoculated with primers and probes in trehalose solution \[[@RSOS172472C17]\]. This format included two sets of multiplex PCR amplification: one for BKV and JCV, the other for B19V and HBV. Primers and TaqMan probes designed for each virus are shown in the electronic supplementary material, table S2. An aliquot of 50 µl of reaction mixture consisting of 500 ng of the cellular DNA with AmpliTaq Gold DNA Polymerase (Applied BioSystems, USA, N8080245) or Taq DNA Polymerase (Thermo Fisher Scientific, USA, EP0406) was added to each well. The assay was conducted using the Applied Biosystems 7300 Real-Time PCR System, with an initial denaturation at 95°C for 10 min, followed using 50 cycles of 95°C for 15 s and 60°C for 1 min for the AmpliTaq Gold DNA Polymerase or with an initial denaturation at 95°C for 1 min followed by 45 cycles of 95°C for 10 s and 60°C for 30 s for Taq DNA Polymerase.

2.5.. Detection of viral RNA with One-Step RT-PCR {#s2e}
-------------------------------------------------

Viral RNA was examined for six kinds of RNA viruses ([table 1](#RSOS172472TB1){ref-type="table"}), HAV, HCV, HTLV-1, HTLV-2, HIV-1 and HIV-2. The reaction mixture using the One-Step PrimeScript RT-PCR Kit (TaKaRa, Japan, RRO64A) was prepared by adding 100 ng of total RNA following the manufacture\'s protocol. Primers and TaqMan probes are shown in the electronic supplementary material, table S3. PCR was carried out using the Applied Biosystems 7300 Real-Time PCR System under conditions consisting of 42°C for 5 min and 95°C for 10 s followed by 50 cycles of 95°C for 5 s and 60°C for 34 s.

2.6.. Reverse Transcriptase Assay {#s2f}
---------------------------------

Some cell lines were transfected with the luciferase expressing gene using retrovirus or lentivirus vectors. To examine lentivirus replication, the cultured medium of these cell lines was centrifuged at 250*g* for 10 min at 4°C to remove cell debris. The supernatant was concentrated by centrifugation (22 000*g*) for 2 h at 4°C, then the pellets were analysed by the Reverse Transcriptase Assay (Roche, Germany, 11468120910) as described by the manufacturer.

3.. Results {#s3}
===========

Our virus test detected six viruses, EBV, HTLV-1, HBV, B19V, HHV-6 and HHV-7, in 43 cell lines ([table 2](#RSOS172472TB2){ref-type="table"}). One of them, AT(L)7KY, was positive for both EBV and HHV-7. Six cell lines are sublines, corresponding to three individuals, owing to duplicated registrations, different names or misidentification. The other nine viruses were not found in any of the 844 cell lines. Whole results are listed in the electronic supplementary material, table S1 in which positive data are shown by Ct value or DNA copy number. All cell lines were negative for bacterial microorganisms. Table 2.Summary of virus screening in human cell lines.*in vivo* infectionpositive virusnumber of cell linesdisease associateddisease unrelatedtransformed *in vitro* EBV30\*12216 HTLV-16114 HBV44 B19V22 HHV-611 HHV-71\*1 \*double positive−1subtotal43negative801total84417720

3.1.. EBV {#s3a}
---------

The most common virus we detected in human cell lines was EBV, found in 30 cell lines, all of which are derived from blood cells ([table 3](#RSOS172472TB3){ref-type="table"}.1). Two of them, P32/ISH and ITSM, have not been reported to be EBV positive and have been identified in this study. EBV is closely associated with endemic Burkitt lymphoma, but this is low in Japanese cases \[[@RSOS172472C18]\]. Six of nine Burkitt lymphoma cell lines, Daudi, HS-Sultan, Namalwa, NC-37, P32/ISH and RAJI, were positive for EBV in contrast to three negative cell lines, KHM-10B, Minami-2 and Ramos (RA1). NC-37 is a misidentified cell line and has been revealed as the derivative of RAJI. Except for P32/ISH, the other five positive cell lines different from Japanese origin showed a high copy number of EBV. P32/ISH, as described previously \[[@RSOS172472C19]\], has an immature B-cell phenotype on the basis of immunological surface marker analysis. EBV nuclear antigen and terminal deoxynucleotidyl transferase activity were negative, which would be related to low copy number of EBV. The other eight EBV-positive cell lines were established from different haematological diseases, leukaemia, multiple myeloma, lymphoma, pseudomyxoma peritonei or severe chronic active EBV infection. One of them, KAI3, is non-B-cell and has been reported as an NK-like cell line \[[@RSOS172472C20]\]. RPMI 1788 was not associated with any disease and was established from normal cells, which would be EBV positive *in vivo*. Table 3.List of virus-positive cell lines. Bold italic names indicate cell lines first identified as virus positive in this report. Bold italic origins show different tropism compared to available data.cell nameorigin of tissue or cellJCRB registration no.1. EBV-positive cell lines** **1.1. Burkitt lymphoma  DaudiB lymphocyteJCRB9071  HS-SultanB lymphocyteJCRB9062  NamalwaB lymphocyteIFO50040  NC-37^a^Identical STR profile with the RAJI cell lineIFO50039  ***P32/ISH***B lymphocyteJCRB0095  RAJI^a^B lymphocyteJCRB9012 1.2. leukaemia, myeloma, lymphoma  CCRF-SBB lymphoblastoid leukaemiaJCRB0032  IM-9B lymphoblastoid multiple myelomaJCRB0024  KAI3NK-like cell line from a patient with severe chronic active EBV infectionIFO50518  RM-P1B cell primary effusion lymphomaJCRB1650  SLVLB cell lymphomaJCRB0159  WIL2-NSB lymphocyteJCRB9063 1.3. disease-unrelated *in vivo* infection  ***ITSM***pseudomyxoma peritonei, cecumJCRB1635  RPMI 1788peripheral blood from normal individualJCRB0035 1.4. *in vitro* EBV transformed  AT(L)5KYperipheral blood, ataxia telangiectasia patientJCRB0331  AT(L)6KYperipheral blood, ataxia telangiectasia patientJCRB0332  AT(L)7KYperipheral blood, ataxia telangiectasia patient, HHV-7 positiveJCRB0333  BSL2KAperipheral blood, Bloom syndrome patientJCRB1042  GM1526peripheral blood, ataxia telangiectasia patientJCRB3008  HLCL-1peripheral lymphocyte, normalJCRB0041  KCMC-1528peripheral blood, Rubinstein--Taybi syndrome patientJCRB1541  NCC-CoC-K115Bperipheral blood, colon cancer patientJCRB1339  RB182F(L)peripheral blood, father of retinoblastoma patientJCRB3038  RB257F(L)peripheral blood, father of retinoblastoma patientJCRB3037  RBL162Tperipheral blood, retinoblastoma patientJCRB0328  RBL182Tperipheral blood, retinoblastoma patientJCRB0330  RBL221Tperipheral blood, retinoblastoma patientJCRB0329  TK6(IVGT)lymphoblastJCRB1435  XPL15OSperipheral blood, xeroderma pigmentosum patientJCRB0307  XPL3KAperipheral blood, xeroderma pigmentosum patientJCRB03062. HTLV-1-positive cell lines KHM-3S***small cell lung cancer***JCRB0138 MT-1lymphoid cell line from adult T-cell leukaemia, low level HTLV-1 producerJCRB1209 MT-2human cord leucocyte cell line established by co-cultivation with human ATL cellsJCRB1210 MT-3human cord leucocyte cell line established by co-cultivation with human ATL cellsJCRB1217 MT-4^b^human cord leucocyte cell line established by co-cultivation with human ATL cellsJCRB0135 MT-4^b^human cord leucocyte cell line established by co-cultivation with human ATL cellsJCRB12163. HBV-positive cell lines Alexander cells^c^hepatoma, HBs antigen-positiveIFO50069 huH-1hepatoma, HBs antigen-positiveJCRB0199 JHH-7hepatomaJCRB1031 PLC/PRF/5^c^hepatoma, HBs antigen-positiveJCRB04064. B19V-positive cell lines ***FPC5JTO***skin fibroblast of familial polyposis coli patientJCRB0318 ***XP2SA***skin fibroblast of xeroderma pigmentosum (variant type) patientJCRB03055. HHV-6-positive cell line HUV-EC-C***human vascular endothelial cell***IFO502716. HHV-7-positive cell line ***AT(L)7KY***peripheral blood, ataxia telangiectasia patient, EBV transformedJCRB0333[^2]

Compared with these 14 EBV-positive cell lines originated from *in vivo* infection, 16 lymphoblastoid cell lines were established from *in vitro* transformation of peripheral blood mononuclear cells using EBV. They were obtained from patients with retinoblastoma and their parents, or patients with a rare disease such as Bloom syndrome, ataxia telangiectasia or xeroderma pigmentosum. Different from these cell lines related to inherited diseases, TK6(IVGT) is characterized by being heterozygous for thymidine kinase and has been used for *in vitro* mutagenesis assays \[[@RSOS172472C21]\]. EBV-transformed cell lines generally proliferate well, and high copy number of EBV was detected.

3.2.. HTLV-1 {#s3b}
------------

HTLV-1 was detected in six cell lines, one lung cancer and four leucocytes ([table 3](#RSOS172472TB3){ref-type="table"}.2). KHM-3S was established from pleural effusion of a patient with small cell lung cancer and showed negative for leucocyte common antigen \[[@RSOS172472C22]\], indicating its unique tropism. MT-1 was derived from a patient with adult T-cell leukaemia (ATL), which shows strong association with HTLV-1 \[[@RSOS172472C23]\]. These two cell lines originated from an *in vivo* infection. MT-2, MT-3 and MT-4 were established by co-culture with lymphoid cells from ATL patients and were infected with HTLV-1 *in vitro* \[[@RSOS172472C24]\]. The viral RNA was detected from these six cell lines and the DNA showed a high copy number. Five types of HTLV-1 proviral sequences were detected in 11 different sites of the MT-2 genome, indicating the integration \[[@RSOS172472C25]\]. It is reported that these MT-1, MT-2, MT-3 and MT-4 cell lines are virus-producing cell lines \[[@RSOS172472C26]\].

3.3.. HBV {#s3c}
---------

HBV was detected from three hepatoma cell lines, huH-1, JHH-7 and PLC/PRF/5 ([table 3](#RSOS172472TB3){ref-type="table"}.3). PLC/PRF/5 is also known as Alexander cells, registered as IFO50069. The viral DNA copy number varied between these cell lines. It is reported that huH-1 and PLC/PRF/5 carry hepatitis B surface antigen (HBsAg) \[[@RSOS172472C27]\]. Although the target region of our real-time PCR is the S gene coding for HBsAg of the virus envelope, the antigen was not detected in JHH-7 \[[@RSOS172472C28]\]. Two integration sites composed of incomplete HBV genome are identified in the JHH-7 genome \[[@RSOS172472C28]\]. Other hepatoma cell lines without HBsAg, JHH-1, -2, -4, -5 and -6, were negative for HBV \[[@RSOS172472C28]\], indicating that JHH-7 exhibits a distinctive feature in the HBV-positive cells.

3.4.. B19V {#s3d}
----------

B19V was detected in two cell lines, FPC5JTO and XP2SA ([table 3](#RSOS172472TB3){ref-type="table"}.4), which could be the first cell lines positive for B19V, originated from *in vivo* infection. These cell lines were fibroblast derived from the skin of patients with hereditary diseases, carrying a high cancer risk. Different from the EBV, HTLV-1 and HBV detected mostly in cancer cell lines, the two B19V-positive cell lines have no association with diseases. Their copy numbers were low, which would be related to their primary cells. Although B19V can propagate in a leukaemia cell line, UT-7 \[[@RSOS172472C29]\], the positive cell lines have not been registered with any major public cell banks.

3.5.. HHV-6 {#s3e}
-----------

HHV-6 was detected in a human vascular endothelial cell line, HUV-EC-C, derived from normal umbilical cord tissue ([table 3](#RSOS172472TB3){ref-type="table"}.5). We have previously reported that chromosomally integrated HHV-6B has been identified at the distal end of chromosome 9q in this particular cell line \[[@RSOS172472C30]\]. The copy number is calculated to be one copy per cell, indicating that the integration could have occurred in the germ line. The viral integration in the HUV-EC-C cell line would be caused by *in vivo* infection. This is distinct from other HHV-6-positive cell lines generated by *in vitro* transfection \[[@RSOS172472C31]\].

3.6.. HHV-7 {#s3f}
-----------

HHV-7 was detected in one cell line, AT(L)7KY, which was not previously reported to be positive. This cell line is a B-cell line transformed by EBV, indicating that both EBV and HHV-7 can be detected in this cell line ([table 3](#RSOS172472TB3){ref-type="table"}.6). It was established from peripheral blood mononuclear cells of a patient with ataxia telangiectasia, which is not associated with HHV-7 infection. Different from HHV-7-infected cell lines transduced with an adenovirus vector \[[@RSOS172472C32]\], AT(L)7KY is, to the best of our knowledge, the first report of an HHV-7-positive cell line likely to be originated from *in vivo* infection which remains detectable in cell culture.

3.7.. HIV-1 and HIV-2 {#s3g}
---------------------

A very small copy number of DNA fragments targeting the gag gene of HIV-1 and LTR of HIV-2 were detected in some of the luciferase-expressing cell lines (electronic supplementary material, table S4). However, these viral RNAs were not detected in these cell lines, and reverse transcriptase activity was below the detection limit. The absence of the RNA and reverse transcriptase in these cell lines confirmed that the cell lines are negative for HIV-1 and HIV-2. The luciferase gene was introduced into these cell lines by the lentiviral vector \[[@RSOS172472C33]\], which may be associated with the detection by PCR. Because HIV-1 and HIV-2 are highly pathogenic and must be handled under biosafety level 3 (BSL3), such cell lines are not received and distributed from our JCRB Cell Bank. All cell lines examined in this study are free of HIV-1 and HIV-2, which minimizes safety concerns over the use of our cell lines.

4.. Discussion {#s4}
==============

Virus infection is one of the major public health concerns and is related to disease pathogenesis \[[@RSOS172472C34]\]. Virus tests have been established for clinical samples in diagnostic laboratories \[[@RSOS172472C9]--[@RSOS172472C11]\]. These tests are also routinely performed on donated blood to avoid infections through blood products. Blood samples are examined mainly by targeting antigens or antibodies detected in plasma. Positive results from these indirect methods identify individuals carrying a viral infection, but do not specify which cells carry the virus. Different from those on *in vivo* samples, our virus tests for cell lines detect viral DNA or RNA in the cytoplasm or the nuclei. The presence of these viral components in cells can be a molecular characterization of the cell line.

Our previous study demonstrated that chromosomally integrated HHV-6B has been identified in a human vascular endothelial cell line, HUV-EC-C (IFO50271) \[[@RSOS172472C15]\]. The analysis of the HUV-EC-C cells reveals that integration of HHV-6B is stable during long-term culture of HUV-EC-C, despite genomic instability in the host cell. A complete HHV-6 genome can be present as the form of integration into the host germ line genome \[[@RSOS172472C35]\], leading to the unexpected detection in different cell types of tropism observed as the HUV-EC-C cell line. It was reported that a human B cell line, RPMI 1788, was established from the peripheral blood of a normal donor and labelled as normal cells \[[@RSOS172472C36]\], however this cell line was found to be EBV positive in another study \[[@RSOS172472C37]\]. This suggests that lymphocytes had been infected with EBV *in vivo*, leading to establishment of the immortalized cell line. These examples show that further investigation of virus-positive cell lines could lead to an understanding of viral dynamics and that such cell lines can serve as invaluable research materials. Virus tests contribute to the characterization of cell lines and elucidation of cellular origins. Because each cell line is derived from a specific tissue and established from a certain cell population in the sample, cell lines that show negative on virus tests are not necessarily derived from uninfected individuals.

Cells *in vitro* always have a risk of viral infection in the culture environment because, by themselves, they lack a defence system against infection. Assessment of virus contamination in cells is undertaken for the purpose of risk management \[[@RSOS172472C38]\]. When cell lines are used as biological products in the biotechnology industry, quality control is strictly maintained during production \[[@RSOS172472C39]\]. Examination of the parainfluenza virus has been performed in 123 human cell lines without any such infection being detected, assuring that those lines are free from the infection \[[@RSOS172472C40]\]. Another study of a screen for murine leukaemia viruses in 577 human cell lines reported that 17 of these cell lines produced active retroviruses \[[@RSOS172472C41]\]. This implies that human cell lines have a risk of viral contamination through transplantation of cells into mice, which is distinguished from *in vivo* infection characterizing cell lines. The use of human cell lines is accompanied by a potential biohazard, because virus tests are limited to certain species and do not cover all pathogens. It is recommended that human cell lines are primarily handled at a biosafety level 2 laboratory, regardless of results from virus tests. Especially, cell lines which produce virus particles need careful handling and their application should be restricted. Each virus has distinct host cell tropisms, implying that negative results would be expected from the majority of cell lines. Because it is not clear that viral tropism is identical between *in vivo* and *in vitro* environments, we applied the whole set of virus tests to all cell types. Apart from the cell lines transformed using EBV or HTLV-1 by *in vitro* infection, 22 cell lines had been infected with virus *in vivo* before their establishment. Of them, two cell lines are inconsistent with the cellular tropism, showing unexpected results.

It is reported that induced pluripotent stem cells can be established from EBV-transformed lymphoblastoid cell lines, and that the reprogrammed cells have been shown to be EBV free \[[@RSOS172472C42],[@RSOS172472C43]\]. This suggests that a change in cell type could lead to elimination of viruses infecting cell lines. These viruses might present in the form of episomes in cells, which are different from integration into host genomes. Differences in the form of viruses in cells would be related to the amount of virus present during cell culture. In this report, human papillomavirus (HPV) is excluded because it has diverse genotypes related to malignant potential, which we will analyse in a future study. Analyses of RNA sequencing data led to identification of EBV, HHV-8 and HTLV-1 in lymphoma cell lines \[[@RSOS172472C44]\]. DNA sequence data from a large number of human cancer cell lines have been accumulated in the Cancer Cell Line Encyclopedia (CCLE) \[[@RSOS172472C45]\] and the Catalogue of Somatic Mutations in Cancer (COSMIC) \[[@RSOS172472C46]\]. Virus-positive cell lines will be identified from these databases, and bioinformatics approaches will help to investigate viral integration sites and genotypes.
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[^1]: Electronic supplementary material is available online at <https://dx.doi.org/10.6084/m9.figshare.c.4068770>.

[^2]: Six cell lines are sublines consisting of three different *in vivo* origins.

    ^a^Identical origin because of misidentification in NC-37.

    ^b^Different registration numbers due to independent depositions.

    ^c^PLC/PRF/5 has also been used as Alexander cells.
